Carestream Health’s recent decision to sell its healthcare information systems business to Royal Philips has been greeted with a mostly positive reaction from the imaging industry, according to a new market report.

CMS has updated its drug spending dashboards with data for 2017, adding information for “thousands” more drugs included in Medicare Parts B and D and Medicaid to its publicly accessible database.

A three-month joint investigation by Kaiser Health News and Fortune magazine has painted a disturbing picture of the state of electronic health records across the United States. The reporters spoke with more than 100 sources and found EHRs not only falling far short of their announced aims but also, in some cases, doing considerable harm.

Molecular data from a patient’s breast cancer cells can help predict if they are at an increased risk for recurrence, according to new findings published in Nature.

The American Society for Radiation Oncology (ASTRO) has updated its reference guide for patient safety and high-quality care during radiation therapy treatment.

NVIDIA this week announced plans to buy chipmaker and its collaboration partner Mellanox Technologies for $6.9 billion. The move by the graphics chip giant seeks to help it push into the growing market for data center components by adding to chips that help speed the flow of information across servers.

A new noninvasive imaging technique can identify small abnormalities in the airways of patients with chronic obstructive pulmonary disease (COPD), according to research published in the American Journal of Respiratory and Critical Care Medicine.

Norman E. Sharpless, MD, director of the National Cancer Institute (NCI) since October 2017, has been announced as the new acting commissioner of the FDA. Sharpless replaces Scott Gottlieb, MD, who unexpectedly resigned from the position on March 5.